May 26, 2026 | Benefits preservation, Drug costs, MedBen Rx, Rx Costs, Specialty Drugs
A recent Pharmaceutical Strategies Group analysis shows managing specialty drug costs is now the top priority for employer health plans —surpassing total cost of care. MedBen Rx’s Benefit Preservation Program addresses this by reducing specialty drug spend by an...
May 4, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rebates, Rx Costs, Savings
Specialty drugs account for more than half of total drug spend and are often the largest cost driver for employer pharmacy plans. A recent BenefitPRO article points to biosimilars as a practical solution — and for MedBen Rx clients, the effect is already clear, with...
Feb 23, 2026 | Biosimilars, Cost Savings, Drug costs, MedBen Rx, Rx Costs, Specialty Drugs
Specialty medications continue to dominate pharmacy spend, now accounting for 52% of all U.S. pharmaceutical sales, according to a recent report from the Healthcare Distribution Alliance. With costs often reaching tens — or even hundreds — of thousands of dollars per...
Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Dec 2, 2025 | Alternative Reimbursement Strategies, Cost management, Cost Savings, Direct-to-Employer Contracting, Drug costs, Fair Market Pricing, Forensic claims review, Health care costs, High-cost claims, MedBen Analytics, MedBen Rx, MedBen WellLiving, Rx Costs, Self-funding, Survey
As 2026 approaches, employers and employees alike are seeking greater stability in how they pay for health care. While national costs continue to rise, self-funding give employers a level of control over spending and plan design that traditional coverages often lack....
Sep 23, 2025 | Brian Fargus, Brooke Hupp, Cancer, Conferences, Cost Savings, Drug costs, Health care costs, Innovations, Pharmacy, Prescription, Rx Costs, Savings
The 12th Annual Sherrill-Morgan Healthcare Conference, held September 18-19, convened employers from Ohio, Kentucky, and Tennessee to explore innovative approaches to managing escalating healthcare costs. MedBen was proud to participate, with its sales team delivering...
